Lorlatinib - PF-06463922
NCT03127618 · Status: APPROVED_FOR_MARKETING · Type: EXPANDED_ACCESS
Last updated 2020-05-15
Summary
Lorlatinib expanded access program
Interventions
- DRUG
-
Lorlatinib
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
A Comparison Of A Single PF-04634817 Tablet Dose Compared With A Solution In Healthy Volunteers
NCT01247883 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose Study to Assess the Safety, Tolerability and Pharmacokinetics(PK) of PF-06865571
NCT03092232 ·Status: COMPLETED ·Phase: PHASE1
-
First In Human, Single Escalating Oral Dose Study Of PF-06882961 In Healthy Adult Subjects
NCT03309241 ·Status: COMPLETED ·Phase: PHASE1
-
Study Of Single And Multiple Ascending Doses Of PF-07054894 In Healthy Adult Participants
NCT04388878 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Assess The Safety, Tolerability, And Pharmacokinetics (PK) Of Multiple Doses Of PF-06865571 In Healthy, Including Overweight And Obese, Adult Subjects
NCT03230383 ·Status: COMPLETED ·Phase: PHASE1
-
STUDY OF PF-07321332 IN HEALTHY PARTICIPANTS
NCT04756531 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics And Tolerability Of Subcutaneous Administration Of PF 04236921 In Healthy Volunteers
NCT01166555 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Investigate The Elimination Of PF-06273588 From The Body Following A Single Low Dose.
NCT01408355 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn About Three Forms of The Study Medicine (Ritlecitinib) in Healthy Adults
NCT06172348 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PF-06842874 in Healthy Participants
NCT04124653 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Evaluate The Safety, Tolerability And Plasma Drug Levels Following A Single Dose Of PF-04995274 In Healthy Adult Volunteers
NCT01091272 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-05230907 In Healthy Volunteers
NCT01897142 ·Status: COMPLETED ·Phase: PHASE1
-
An Open-Label, Single-Dose, Mass-Balance Study to Assess the Disposition of 14C-Labeled PRT054021 in Healthy Male Subjects
NCT01765855 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of PF-06852231 in Healthy Subjects
NCT03217604 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Single Ascending Doses of PF-07081532 in Healthy Adult Participants
NCT04148209 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn How the Study Medicine PF-07899895 Are Tolerated and Act in the Body of Healthy Adults
NCT06137729 ·Status: TERMINATED ·Phase: PHASE1
-
A Multiple Dose Study To Determine Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects
NCT01140672 ·Status: COMPLETED ·Phase: PHASE1
-
A Hepatic Impairment Study for PF-04965842.
NCT03626415 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Single and Multiple Ascending Doses of PF-07059013 in Healthy Adult Participants
NCT04323124 ·Status: TERMINATED ·Phase: PHASE1
-
Single Dose Study of PF-06815345 in Healthy Subjects
NCT02654899 ·Status: TERMINATED ·Phase: PHASE1
-
A Study To Investigate The Safety And Toleration Of A Single Dose Of PF-04418948 In Healthy Volunteers
NCT01002963 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of PF-06730512
NCT03146065 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Evaluate Different Formulations Of PF-06865571 In Healthy Subjects
NCT03372044 ·Status: COMPLETED ·Phase: PHASE1
-
Single Ascending Dose Study of Intravenous Infusion of PF 07304814 in Healthy Adult Participants
NCT04627532 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose, Dose Escalation Healthy Volunteers Study Of PF-05105679
NCT01393652 ·Status: COMPLETED ·Phase: PHASE1